跳至主要内容
临床试验/NL-OMON41052
NL-OMON41052招募中不适用

Prediction of individual treatment response to biologics by ex-vivo immunological testing in rheumatoid arthritis - BIO-TOP study: Biologic Individual Optimized Treatment Outcome Prediction

Sint Maartenskliniek0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Rheumatoid arthritis (either 2010 ACR RA and/or 1987 RA criteria and/or clinical diagnosis of the treating rheumatologist, fulfilled at any time point between start of the disease and inclusion)
  • Patients with RA who start with (or switch to) a biologic (including abatacept, adalimumab, etanercept, rituximab and tocilizumab)
  • Concomitant treatment with conventional DMARDs and/or NSAIDs is permitted
  • Age >= 18 years
  • Informed consent
  • Ability to measure the study outcome in the patient (e.g. life expectancy >6 months, no planned relocation far away)
  • Ability to read and communicate well in Dutch

排除标准

  • 未提供

研究者

相似试验

已完成
不适用
Onderzoek naar het voorspellen van het effect van biologicals op de ziekteactiviteit van een individuele patiënt met reumatoïde artritis (RA)Rheumatoid arthritis. Biologics. Prediction. Ex-vivo cytokine profiling.
NL-OMON26414Sint Maartenskliniek Nijmegen400
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosis
DRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
招募中
不适用
To Investigate predictors of the efficacies of biologics for rheumatoid arthritis or psoriatic arthritisRheumatoid arthritis, Psoriatic arthritis
JPRN-UMIN000023152Immune-Mediated Diseases Therapy Center, Graduate School of Medicine University of Tokyo80
已完成
不适用
Prediction of the therapeutic response and adverse events to methotrexate by monitoring methotrexate-polyglutamates (MTX-PGs) concentration in erythrocytes in Japanese patients with rheumatoid arthritis (RA).Rheumatoid arthritis
JPRN-UMIN000020134Jichi Medical University56
尚未招募
不适用
Individual predictors of therapy response to dialectical behavioral therapy (DBT) in an inpatient settingF60.31F32Depressive episode
DRKS00024042VR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität160